Health Care Technology

Scienture

Scienture released FY2025 9 Months Earnings on November 12 EST, actual revenue USD 600.31 K, actual EPS USD -1.0002

Scienture released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 590.05 K, actual EPS USD -0.1902

Scienture released FY2025 Q2 earnings on August 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.48

Scienture released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 10.26K, actual EPS USD -0.83

Scienture released FY2025 Q1 earnings on May 12 (EST), actual revenue USD 10.26 K, actual EPS USD -0.33

Scienture released FY2024 Q4 earnings on March 26 (EST), with actual revenue of 53.08 K USD and EPS of -0.8284 USD

Scienture released FY2024 annual earnings on March 26 (EST), with actual revenue of 136.64 K USD and EPS of 2.6811 USD

Scienture released FY2024 9 Months Earnings on November 6 (EST), with actual revenue of USD 83.56K and EPS of USD 17.8412

Scienture released FY2024 Q3 earnings on November 6, 2024 (EST) with actual revenue of 64,861 and EPS of -1.3411

Scienture released FY2023 annual earnings on August 16, 2024 (EST), with actual revenue of 1.364 M USD and EPS of -23.3536 USD

Scienture released FY2023 Q4 earnings on August 16 (EST), with actual revenue of 128.66 K USD and EPS of -12.5183 USD

Scienture released its Annual 2022 Earnings on August 16, 2024 (EST) with actual revenue of 300,000 USD and EPS of -0.7416

Scienture released its Q3 2023 earnings on August 16, 2024 (EST), with actual revenue of 1.18M USD and EPS of -9.4354

Scienture released FY2024 Semi-Annual earnings on August 9, 2024 (EST), with actual revenue of USD 18.7K and EPS of USD 15.8502

Scienture released FY2024 Q2 earnings on August 9 (EST), actual revenue USD 18.7K, actual EPS USD -1.3087

Scienture released FY2024 Q1 earnings on August 9 (EST), actual revenue USD 0, actual EPS USD 20.491

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Veeva Systems -CL

Doximity

Waystar

Phreesia

HealthStream

OptimizeRx

LifeMD

CareCloud

Forian

Certara

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap